Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan

Hidekazu Suzuki, Toshihiro Nishizawa, Hitoshi Tsugawa, Toshifumi Hibi

研究成果: Review article査読

10 被引用数 (Scopus)

抄録

Thirty years have passed since Warren and Marshall's discovery of Helicobacter pylori (H. pylori). Since then, not only peptic ulcer diseases and chronic gastritis but also non-cardia gastric cancers have been recognized as diseases originating from H. pylori infection. Several combination therapies consisting of multiple antibiotics have been developed as first- or second-line regimens to eradicate H. pylori infection. Our extensive experience in the field of anti-H. pylori medicine suggests that clinicians should consider a possible role for unidentified, invisible pathogens to elucidate the pathogenesis and improve the treatment of refractory diseases of unknown etiology.

本文言語English
ページ(範囲)109-119
ページ数11
ジャーナルKeio Journal of Medicine
61
4
DOI
出版ステータスPublished - 2012 12

ASJC Scopus subject areas

  • 医学(全般)

フィンガープリント

「Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル